Bovine Mastitis Treatment System Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, France, India, China - Size and Forecast 2024-2028

Published: Feb 2024

Pages: 159

SKU: IRTNTR77458

Snapshot

Bovine Mastitis Treatment System Market Forecast 2024-2028

The global bovine mastitis treatment system market size is estimated to grow by USD 551.33 million at a CAGR of 5.34% between 2023 and 2028.

The market is expanding due to heightened concerns about food safety. Mastitis affects milk quality and poses risks to consumer health. Dairy farmers invest in treatment systems to detect and address mastitis promptly, ensuring high-quality milk production. Meeting consumer demands for safe dairy products drives the adoption of these systems, enhancing consumer confidence and market competitiveness. Therefore, a growing emphasis on food safety and quality is expected to drive the growth of the global bovine mastitis treatment system market during the forecast period.

The market research and growth report also includes an in-depth analysis of drivers, trends, and challenges. Our market growth analysis report examines historical data from 2018-2022, besides analyzing the current market scenario.

What will be the Size of the Market During the Forecast Period?

To learn more about this report, Download Report Sample

Market Segmentation

Product Analysis

The market share growth by the antibiotics segment will be significant during the forecast period. In the market, antibiotics are essential components in combating mastitis infections and restoring the health of dairy cattle. Several prominent pharmaceutical companies offer a diverse array of antibiotic products tailored specifically for mastitis treatment. Zoetis Inc., a leading animal health company, provides a range of antibiotic treatments, such as ceftiofur, which is a broad-spectrum cephalosporin effective against a variety of mastitis-causing bacteria.

Get a glance at the market contribution of various segments Download PDF Sample

The antibiotics segment was valued at USD 1,292.82 million in 2018. Boehringer Ingelheim International GmbH, another major player in the industry, offers a portfolio of antibiotics, including penicillin-based drugs and cephalosporins formulated to target mastitis pathogens. These companies leverage their extensive research and development capabilities, along with robust distribution networks, to ensure that dairy farmers have access to effective antibiotic solutions for addressing mastitis infections promptly and effectively. These factors will drive the growth of the antibiotics segment of the treatment system market during the forecast period.

End-user Analysis:

The intramammary route of administration for treatment is a widely used method that involves the direct infusion of therapeutic agents into the udder through the teat canal. This targeted approach allows for the delivery of medication directly to the site of infection, maximizing efficacy while minimizing systemic side effects. Market players offer a range of intramammary treatment products designed to combat mastitis infections effectively. Further, as the demand for efficient and sustainable mastitis treatment solutions continues to increase, vendors are expected to innovate and expand their intramammary product offerings to meet the evolving needs of the dairy industry. This, in turn, will drive the growth of the intramammary segment of the market during the forecast period.

The systemic route of administration for bovine mastitis treatment involves the delivery of therapeutic agents through the bloodstream to target mastitis infections throughout the cow body. While less targeted than intramammary administration, systemic treatments are effective in treating both clinical and systemic mastitis cases. Market players offer a variety of systemic treatment options to address mastitis infections in dairy cattle. Furthermore, as the demand for efficient and sustainable mastitis treatment solutions continues to grow, vendors are expected to innovate and expand their systemic product offerings to meet the evolving needs of the dairy industry. This, in turn, will drive the growth of the systemic segment of the market during the forecast period.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 35% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. In North America, the market is well-established, supported by a robust dairy industry and advanced veterinary infrastructure. Market players include multinational pharmaceutical companies, specialized biotechnology firms, and veterinary equipment manufacturers. Pharmaceutical companies are key players in the North American market, supplying antibiotics and other medications essential for mastitis treatment.

Furthermore, dairy farmers and veterinary practitioners in North America rely on vendors operating in the market for access to high-quality products and expert guidance in mastitis prevention and treatment. Through ongoing research, innovation, and lack of knowledge exchange, market players and local partners can continue to advance mastitis control efforts, contributing to the sustainability and profitability of the dairy industry in North America. Hence, such factors are expected to drive market growth in this region during the forecast period.

Buy Full Report Now

Key Market Players

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Bio-Vet: The company offers bovine treatment systems such as Bovine CPR which can be mixed with dry feed, milk, or milk replacer.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Dynamic and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges.

Key Drivers

Integration of PLF technologies is the key factor driving market growth. PLF encompasses the use of advanced sensors, data analytics, and automation to monitor and manage individual animals health and welfare in real time. In the context of bovine mastitis PLF technologies enable dairy farmers to implement more targeted and proactive management strategies, resulting in improved detection, treatment, and prevention of mastitis infections. Furthermore, PLF technologies enable data-driven decision-making and proactive management practices. By integrating data from various sources, including milk quality tests, cow health records, and environmental sensors, PLF systems provide actionable insights and recommendations for mastitis prevention and treatment.

Furthermore, market players like Zoetis Inc. are leveraging PLF technologies to enhance their mastitis treatment systems and provide more personalized and targeted solutions. Additionally, by combining real-time monitoring, advanced analytics, and automated decision-making, these integrated solutions empower dairy farmers to detect mastitis cases earlier, implement targeted interventions more effectively, and optimize udder health outcomes across the herd. Thus, due to such factors, the market is expected to experience significant growth and innovation during the forecast period.

Significant Trends

The emergence and adoption of automated detection systems and precision medicine is one of the primary market trends shaping growth. Technological advances utilize advanced sensors and algorithms to continuously monitor cow behavior, milk production, and udder health parameters in real time. By analyzing subtle changes in cow behavior and milk quality, these systems can detect early signs of mastitis, allowing farmers to intervene promptly and prevent the spread of infection within the herd.

Furthermore, advancements in treatment modalities and delivery systems are driving market growth by offering innovative solutions for mastitis management. These novel approaches enhance treatment efficacy, minimize the use of antibiotics, and reduce the risk of antimicrobial resistance, addressing sustainability concerns and regulatory pressures faced by the dairy industry. Therefore, rising technological advancements are expected to drive market growth during the forecast period.

Major Challenges

Lack of awareness about the importance of proactive mastitis management practices among dairy farmers is a challenge that affects market growth. Many farmers, especially in developing regions, may not fully understand the preventive measures and treatment options available to combat mastitis effectively. Without adequate awareness and education, farmers may overlook early signs of mastitis or fail to implement proper hygiene protocols and preventative measures on their farms. This can lead to increased incidence of mastitis cases, reduced milk production, and higher veterinary costs, ultimately impacting the profitability and sustainability of dairy operations.

Additionally, farmers may continue to rely on traditional treatment methods, such as blanket antibiotic therapy, which can contribute to antimicrobial resistance and compromise the effectiveness of mastitis treatment over time. Therefore, the lack of awareness and education among dairy farmers regarding the importance of proactive mastitis management practices is expected to hinder the growth of the market during the forecast period.

Buy Now Full Report

Key Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market growth and forecasting report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Customer Landscape

Market Analyst Overview

The market encompasses innovative solutions for addressing mastitis in dairy cows. This condition, affecting the Mammary glands, can lead to decreased milk production and increased use of antibiotic resistance. New products in this market include the use of ice cubes on teats to alleviate inflammation and the application of phenol for teat disinfection. Large companies, such as Boehringer Ingelheim International GmbH, are investing in the development of lockout products to prevent contamination and strengthen the immune system of dairy cows. Strategic mergers between industry players aim to create synergistic effects, enhancing the end products of dairy farming and ensuring the health and productivity of dairy herds.

Segment Overview

The market report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2018 to 2028.

Product Outlook
- Antibiotics
- Others

Route Of Administration Outlook
- Intramammary
- Systemic

Region Outlook
- North America
  - The U.S.
  - Canada
- Europe
  - The U.K.
  - Germany
  - France
  - Rest of Europe
- Asia
  - China
  - India
- Rest of World (ROW)
  - Australia
  - Argentina
  - Brazil

Bovine Mastitis Treatment System Market Scope
Report Coverage	Details
Page number	159
Base year	2023
Historic period	2018-2022
Forecast period	2024-2028
Growth momentum & CAGR	Accelerate at a CAGR of 5.34%
Market Growth 2024-2028	USD 551.33 million
Market structure	Fragmented
YoY growth 2023-2024(%)	4.5
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 35%
Key countries	US, Germany, France, India, and China
Competitive landscape	Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks
Key companies profiled	Advanced Animal Diagnostics, Armenta, Bio-Vet, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Elanco Animal Health Inc., Endovac Animal Health, Forte Healthcare Ltd., HIPRA S A, Huvepharma EOOD, ImmuCell Corp., Merck KGaA, Neogen Corp., Nimrod Veterinary Products Ltd., Norbrook Laboratories Ltd., Vetoquinol SA, Virbac Group, West Way Health, Zoetis Inc., and Thermo Fisher Scientific Inc.
Market dynamics	Parent market analysis, Market Forecasting ,Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Market Research Report?

CAGR of the market during the forecast period
Detailed information on factors that will drive the growth of the between 2024 and 2028
Precise estimation of the size and its contribution to the market in focus on the parent market
Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria
Companies landscape comparing criticality of inputs and factors of differentiation
Exclusive Matrix on companies' position and classification
Accurate predictions about upcoming trends and changes in consumer behavior
Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
A thorough analysis of the market’s competitive landscape and detailed information about companies
Comprehensive analysis of factors that will challenge the growth of companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

Table of Contents

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Route of Administration
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global bovine mastitis treatment system market 2018 - 2022
- Exhibit 18: Historic Market Size – Data Table on global bovine mastitis treatment system market 2018 - 2022 ($ million)

4.2 Product Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size – Product Segment 2018 - 2022 ($ million)

4.3 Route of Administration Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size – Route of Administration Segment 2018 - 2022 ($ million)

4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)

4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

6.1 Market segments
- Exhibit 30: Chart on Product - Market share 2023-2028 (%)
- Exhibit 31: Data Table on Product - Market share 2023-2028 (%)

6.2 Comparison by Product
- Exhibit 32: Chart on Comparison by Product
- Exhibit 33: Data Table on Comparison by Product

6.3 Antibiotics - Market size and forecast 2023-2028
- Exhibit 34: Chart on Antibiotics - Market size and forecast 2023-2028 ($ million)
- Exhibit 35: Data Table on Antibiotics - Market size and forecast 2023-2028 ($ million)
- Exhibit 36: Chart on Antibiotics - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Antibiotics - Year-over-year growth 2023-2028 (%)

6.4 Others - Market size and forecast 2023-2028
- Exhibit 38: Chart on Others - Market size and forecast 2023-2028 ($ million)
- Exhibit 39: Data Table on Others - Market size and forecast 2023-2028 ($ million)
- Exhibit 40: Chart on Others - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Others - Year-over-year growth 2023-2028 (%)

6.5 Market opportunity by Product
- Exhibit 42: Market opportunity by Product ($ million)
- Exhibit 43: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Route of Administration

7.1 Market segments
- Exhibit 44: Chart on Route of Administration - Market share 2023-2028 (%)
- Exhibit 45: Data Table on Route of Administration - Market share 2023-2028 (%)

7.2 Comparison by Route of Administration
- Exhibit 46: Chart on Comparison by Route of Administration
- Exhibit 47: Data Table on Comparison by Route of Administration

7.3 Intramammary - Market size and forecast 2023-2028
- Exhibit 48: Chart on Intramammary - Market size and forecast 2023-2028 ($ million)
- Exhibit 49: Data Table on Intramammary - Market size and forecast 2023-2028 ($ million)
- Exhibit 50: Chart on Intramammary - Year-over-year growth 2023-2028 (%)
- Exhibit 51: Data Table on Intramammary - Year-over-year growth 2023-2028 (%)

7.4 Systemic - Market size and forecast 2023-2028
- Exhibit 52: Chart on Systemic - Market size and forecast 2023-2028 ($ million)
- Exhibit 53: Data Table on Systemic - Market size and forecast 2023-2028 ($ million)
- Exhibit 54: Chart on Systemic - Year-over-year growth 2023-2028 (%)
- Exhibit 55: Data Table on Systemic - Year-over-year growth 2023-2028 (%)

7.5 Market opportunity by Route of Administration
- Exhibit 56: Market opportunity by Route of Administration ($ million)
- Exhibit 57: Data Table on Market opportunity by Route of Administration ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 59: Chart on Market share by geography 2023-2028 (%)
- Exhibit 60: Data Table on Market share by geography 2023-2028 (%)

9.2 Geographic comparison
- Exhibit 61: Chart on Geographic comparison
- Exhibit 62: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2023-2028
- Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)

9.4 Europe - Market size and forecast 2023-2028
- Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)

9.5 Asia - Market size and forecast 2023-2028
- Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)

9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

9.7 US - Market size and forecast 2023-2028
- Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)

9.8 India - Market size and forecast 2023-2028
- Exhibit 83: Chart on India - Market size and forecast 2023-2028 ($ million)
- Exhibit 84: Data Table on India - Market size and forecast 2023-2028 ($ million)
- Exhibit 85: Chart on India - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on India - Year-over-year growth 2023-2028 (%)

9.9 Germany - Market size and forecast 2023-2028
- Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)

9.10 China - Market size and forecast 2023-2028
- Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)

9.11 France - Market size and forecast 2023-2028
- Exhibit 95: Chart on France - Market size and forecast 2023-2028 ($ million)
- Exhibit 96: Data Table on France - Market size and forecast 2023-2028 ($ million)
- Exhibit 97: Chart on France - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on France - Year-over-year growth 2023-2028 (%)

9.12 Market opportunity by geography
- Exhibit 99: Market opportunity by geography ($ million)
- Exhibit 100: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 101: Impact of drivers and challenges in 2023 and 2028

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 102: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 103: Overview on factors of disruption

11.4 Industry risks
- Exhibit 104: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 105: Vendors covered

12.2 Market positioning of vendors
- Exhibit 106: Matrix on vendor position and classification

12.3 Advanced Animal Diagnostics
- Exhibit 107: Advanced Animal Diagnostics - Overview
- Exhibit 108: Advanced Animal Diagnostics - Product / Service
- Exhibit 109: Advanced Animal Diagnostics - Key offerings

12.4 Bio-Vet
- Exhibit 110: Bio-Vet - Overview
- Exhibit 111: Bio-Vet - Product / Service
- Exhibit 112: Bio-Vet - Key offerings

12.5 Boehringer Ingelheim International GmbH
- Exhibit 113: Boehringer Ingelheim International GmbH - Overview
- Exhibit 114: Boehringer Ingelheim International GmbH - Business segments
- Exhibit 115: Boehringer Ingelheim International GmbH - Key news
- Exhibit 116: Boehringer Ingelheim International GmbH - Key offerings
- Exhibit 117: Boehringer Ingelheim International GmbH - Segment focus

12.6 Ceva Sante Animale
- Exhibit 118: Ceva Sante Animale - Overview
- Exhibit 119: Ceva Sante Animale - Product / Service
- Exhibit 120: Ceva Sante Animale - Key offerings

12.7 Elanco Animal Health Inc.
- Exhibit 121: Elanco Animal Health Inc. - Overview
- Exhibit 122: Elanco Animal Health Inc. - Product / Service
- Exhibit 123: Elanco Animal Health Inc. - Key offerings

12.8 Endovac Animal Health
- Exhibit 124: Endovac Animal Health - Overview
- Exhibit 125: Endovac Animal Health - Product / Service
- Exhibit 126: Endovac Animal Health - Key offerings

12.9 HIPRA S A
- Exhibit 127: HIPRA S A - Overview
- Exhibit 128: HIPRA S A - Product / Service
- Exhibit 129: HIPRA S A - Key offerings

12.10 ImmuCell Corp.
- Exhibit 130: ImmuCell Corp. - Overview
- Exhibit 131: ImmuCell Corp. - Business segments
- Exhibit 132: ImmuCell Corp. - Key offerings
- Exhibit 133: ImmuCell Corp. - Segment focus

12.11 Merck KGaA
- Exhibit 134: Merck KGaA - Overview
- Exhibit 135: Merck KGaA - Business segments
- Exhibit 136: Merck KGaA - Key news
- Exhibit 137: Merck KGaA - Key offerings
- Exhibit 138: Merck KGaA - Segment focus

12.12 Nimrod Veterinary Products Ltd.
- Exhibit 139: Nimrod Veterinary Products Ltd. - Overview
- Exhibit 140: Nimrod Veterinary Products Ltd. - Product / Service
- Exhibit 141: Nimrod Veterinary Products Ltd. - Key offerings

12.13 Norbrook Laboratories Ltd.
- Exhibit 142: Norbrook Laboratories Ltd. - Overview
- Exhibit 143: Norbrook Laboratories Ltd. - Product / Service
- Exhibit 144: Norbrook Laboratories Ltd. - Key offerings

12.14 Thermo Fisher Scientific Inc.
- Exhibit 145: Thermo Fisher Scientific Inc. - Overview
- Exhibit 146: Thermo Fisher Scientific Inc. - Business segments
- Exhibit 147: Thermo Fisher Scientific Inc. - Key news
- Exhibit 148: Thermo Fisher Scientific Inc. - Key offerings
- Exhibit 149: Thermo Fisher Scientific Inc. - Segment focus

12.15 Vetoquinol SA
- Exhibit 150: Vetoquinol SA - Overview
- Exhibit 151: Vetoquinol SA - Business segments
- Exhibit 152: Vetoquinol SA - Key news
- Exhibit 153: Vetoquinol SA - Key offerings
- Exhibit 154: Vetoquinol SA - Segment focus

12.16 Virbac Group
- Exhibit 155: Virbac Group - Overview
- Exhibit 156: Virbac Group - Business segments
- Exhibit 157: Virbac Group - Key news
- Exhibit 158: Virbac Group - Key offerings
- Exhibit 159: Virbac Group - Segment focus

12.17 Zoetis Inc.
- Exhibit 160: Zoetis Inc. - Overview
- Exhibit 161: Zoetis Inc. - Business segments
- Exhibit 162: Zoetis Inc. - Key news
- Exhibit 163: Zoetis Inc. - Key offerings
- Exhibit 164: Zoetis Inc. - Segment focus

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 165: Inclusions checklist
- Exhibit 166: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 167: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 168: Research methodology
- Exhibit 169: Validation techniques employed for market sizing
- Exhibit 170: Information sources

13.5 List of abbreviations
- Exhibit 171: List of abbreviations

Methodology

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

Manufacturers and suppliers
Channel partners
Industry experts
Strategic decision makers

Secondary sources

Industry journals and periodicals
Government data
Financial reports of key industry players
Historical data
Press releases

DATA ANALYSIS

Data Synthesis

Collation of data
Estimation of key figures
Analysis of derived insights

Data Validation

Triangulation with data models
Reference against proprietary databases
Corroboration with industry experts

REPORT WRITING

Qualitative

Market drivers
Market challenges
Market trends
Five forces analysis

Quantitative

Market size and forecast
Market segmentation
Geographical insights
Competitive landscape

Purchase Report

PURCHASE FULL REPORT OF

bovine mastitis treatment system market market

Buy Report - Single User License 2500 USD

QUICK BUY

Key Questions Answered

What are the key global market and the regional market share?
What are the revenue-generating key market segments?
What are the key factors driving and challenging this market’s growth?
Who are the key market vendors and their growth strategies?
What are the latest trends influencing the growth of this market?
What are the variables influencing the market growth in the primary regions?
What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

Off-the-shelf research reports
Reports can be tailored to meet the customer's needs
Trusted by more than 100 fortune 500 organizations
Information about the market's key drivers, trends, and challenges
Parent market analysis
Every week, 50,000 people visit our subscription platform
Detailed vendors report with competitive landscape
Covid-19 impact and recovery analysis
Data on revenue-generating market segments
Details on the market shares of various regions
Five-force market analysis